Maria Cristina works in the health sector as the CEO and co-founder of PLAMIC. For healthcare clients worldwide, PLAMIC is an advanced healthcare startup that uses innovative microfluidic technology that is reproducible, scalable, and cost-effective to revolutionize nanomedicine production by enhancing existing medications, making them safer, more effective, and with fewer side effects to improve patient care. Maria Cristina’s short-term goal is to implement concrete strategies that accelerate the company’s business growth and foster key collaborations. Their long-term goal is to establish PLAMIC as a global leader in nanomedicine technology, creating a lasting positive impact on healthcare. Coming into the YLAI Fellowship, Maria Cristina’s top business challenge is Strategy.